期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 51, 期 15, 页码 4708-4714出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm800422v
关键词
-
资金
- NHLBI NIH HHS [R37 HL036235, R37HL036235, R01 HL036235, R01 HL036235-19] Funding Source: Medline
We report a series of inhibitors of secreted phospholipases A(2) (sPLA(2)S) based on substituted indoles, 6,7-benzoindoles, and indolizines derived from LY315920, a well-known indole-based sPLA(2) inhibitor. Using the human group X sPLA2 crystal structure, we prepared a highly potent and selective indole-based inhibitor of this enzyme. Also, we report human and mouse group IIA and HE specific inhibitors and a substituted 6,7-benzoindole that inhibits nearly all human and mouse sPLAs in the low nanomolar range.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据